Pfizer (PFE) SVP uses 419 shares to cover RSU tax withholding

Rhea-AI Filing Summary

Pfizer Inc. senior vice president and controller Jennifer B. Damico reported a tax-related share disposition. On the vesting of restricted stock units, 419 shares of common stock were withheld at $27.06 per share to satisfy tax obligations, leaving her with 12,186 directly held shares.

Insider Trade Summary

Net Seller: 419 shares

Net Sell 1 txn

Insider DAMICO JENNIFER B.

Role SVP & Controller

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	419	$27.06	$11K

Holdings After Transaction: Common Stock — 12,186 shares (Direct)

Footnotes (1)

1. F1. The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 02/24/2026 - 03:40 PM Learn about SEC filing dates

FAQ

What insider transaction did Pfizer (PFE) report for Jennifer B. Damico?

Pfizer reported that SVP & Controller Jennifer B. Damico had 419 common shares withheld to cover tax obligations on vesting restricted stock units. This tax-withholding disposition was recorded at $27.06 per share, leaving her with 12,186 directly owned shares afterward.

Was the Pfizer (PFE) insider Form 4 a discretionary sale of shares?

The Form 4 shows a tax-withholding disposition, not an open-market sale. 419 shares were withheld to satisfy tax obligations upon vesting of restricted stock units and related dividend equivalents, consistent with transaction code F and the accompanying footnote description.

How many Pfizer (PFE) shares does Jennifer B. Damico hold after this Form 4?

After the reported tax-withholding transaction, Jennifer B. Damico directly holds 12,186 Pfizer common shares. This figure reflects her position following the withholding of 419 shares used to pay taxes on recently vested restricted stock units and associated dividend equivalents.

What does transaction code F mean in the Pfizer (PFE) insider filing?

Transaction code F indicates payment of an exercise price or tax liability by delivering securities. In this Pfizer filing, 419 shares were withheld to cover tax obligations on the vesting of restricted stock units, matching the code’s description and the provided explanatory footnote.

What price per share was used for the Pfizer (PFE) tax-withholding transaction?

The tax-withholding disposition used a price of $27.06 per Pfizer common share. That price was applied to 419 withheld shares connected to the vesting of restricted stock units and dividend equivalents, as disclosed in the insider Form 4 transaction details.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DAMICO JENNIFER B.

(Last) (First) (Middle)

66 HUDSON BOULEVARD EAST

ATTN: CORPORATE SECRETARY

(Street)

NEW YORK NY 10001-2192

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PFIZER INC [ PFE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP & Controller

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/23/2026		F		419(1)	D	$27.06	12,186	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).

	/s/ Shanice A. Reid, by power of atty, for Jennifer B. Damico	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.